| Financial Year |
March 31 2023 |
| Monetary Funds |
57,634,530.24 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,549,640.08 |
| Accounts Receivable |
86,639,590.52 |
| Advances to Suppliers |
3,526,094.19 |
| Other Receivables |
27,068,619.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
36,755,929.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
722,967.94 |
| Other Current Assets |
9,297,225.38 |
| Total Current Assets |
251,982,111.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,845,129.94 |
| Long-term Equity Investment |
26,348,360.91 |
| Investment Properties |
127,961,106.60 |
| Fixed Assetes |
147,008,207.22 |
| Under-construction Projects |
799,282.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,183,244.46 |
| R&D expenses |
1,858,472.57 |
| Goodwill |
359,972.58 |
| Long-Term Deferred and Prepaid Expenses |
15,158,266.85 |
| Deferred Income Tax Assets |
53,652,654.19 |
| Other Non-Current Assets |
6,762,000.00 |
| Sub-Total of Non-Current Assets |
519,478,737.06 |
| Total Assets |
771,460,848.72 |
| Short-Term Loans |
11,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,625,308.95 |
| Accounts Payable |
149,795,671.49 |
| Accounts Received In Advance |
2,935.78 |
| Employee Compensation Payable |
6,744,381.72 |
| Taxes Payable |
2,623,729.67 |
| Interest Payable |
10,940,201.32 |
| Dividend Payable |
-- |
| Other payables |
272,696,643.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
106,742,264.24 |
| Other Current Liabilities |
1,680,136.83 |
| Sub-Total of Current Liabilities |
556,943,364.27 |
| Long-term Loans |
160,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,020,231.74 |
| Deferred Income Tax Liabilities |
12,423,147.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
181,724,224.81 |
| Total Liabilities |
738,667,589.08 |
| Paid-In Capital(Or Share Stock) |
799,169,568.00 |
| Capital Surplus |
349,673,051.54 |
| Surplus Reserve |
94,448,815.32 |
| LESS:Treasury Stock |
106,743,980.50 |
| Undistributed Profits |
-1,121,384,702.07 |
| Minority Stockholder's Interest |
30,148,352.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,644,906.84 |
| Owner's Equity（Stockholder's Equity） |
32,793,259.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
771,460,848.72 |
